People Directory | SRS Search…

	Departments / Offices	Countries / Centers	Research / Health	Tools / Resources	Policies / Procedures
Health Systems and Services (HSS)  ♦  Essential medicines, strategic supplies & diagnostic reagents       Go!    Agentes diagnóstico  Analgésicos  Antialérgicos  Antianémicos  Antianginoso  Antiarritmicos  Antiasmáticos-EPOC  Antibacterianos  Antichagásicos  Anticoagulantes  Anticonvulsivantes  Antidepresivos  Antidiabéticos  Antídotos  Antieméticos  Antihelminticos  Antihipertensivos  Antileishmaniasicos  Antileprosos  Antimicóticos  Antipalúdicos  Antiparkinsonianos  Antipsicóticos  AntiTB  AntiTB 2da línea  Antitrombóticos  Antiulcerosos  Antivirales  Artritis reumatoide  ARV adultos  ARV pediátricos  Citotóxicos  Contraceptivos  Cuidado paliativo  Desorden bipolar  Diuréticos  Estatinas  Hepatitis  Inmunosupresores  Insuficiencia cardiaca  Neonato  Oxitócicos  Pneumocistosis y toxoplasmosis  Relajantes musculares  Sangre y plasma  Uso de psicoactivos  Vitaminas y minerales Print Preview ANTIVIRALS / ANTIVIRALES Antiretrovirals / Antiretrovirales International Nonproprietary Name (INN) / Denominacion Comun Internacional (DCI) Strength / Concentracion Dosage form / Forma farmaceutica Packing / Envase Packing size / Tamano del envase Packaging type / Tipo de empaque Prequalified by WHO / Precalificado por OMS (1) Link to prequalification list / Enlace a la lista de precalificacion Approved by EMA or other agencies / Aprobado por EMA o por otras agencias (1) Approved by FDA or tentatively approved by FDA / Aprobado o tentativamente aprobado por FDA (1) Indication (s) / Indicacion (es) Notes / Notas Reference price / Precio de referencia (2) Purchase documents / Documentos para compra Abacavir 300 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA371 * Ref: HA494 * Ref: HA575 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 09-1560 2 Ref: USFDA ANDA 07-8742 2 Ref: USFDA ANDA 07-7844 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Abacavir + Lamivudine 600 mg + 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA635 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 20-5412 2 Ref: USFDA ANDA 90-159 2 Ref: USFDA ANDA 09-1144 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Atazanavir 300 mg Capsule / Capsula Bottle / Frasco 30 capsules bottle / Frasco de 30 capsulas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: USFDA ANDA 20-0196 2 Ref: USFDA ANDA 009-1611b 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Atazanavir + Ritonavir 300 mg + 100 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA507 * Ref: HA632 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA NDA 20-5508 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Darunavir 600 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA531 Ref: HA628 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Darunavir 75 mg Tablet / Tableta Bottle / Frasco 160 tablets bottle / Frasco de 160 tabletas HDPE Bottle 160x1 / Frasco PEAD 160x1 Ref: HA529 (a) https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA Age restriction > 3 years old / Restriccion de edad > 3 anos de edad. Upon request / A peticion Darunavir 400 mg Tablet / Tableta Container / Recipiente 60 tablets container / Recipiente de 60 tabletas HDPE Container 60x1 / Recipiente PEAD 60x1 Ref: HA627 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA Age restriction > 3 years old / Restriccion de edad > 3 anos de edad. Upon request / A peticion Darunavir 800 mg Tablet / Tableta HIV-AIDS / VIH-SIDA Age restriction > 3 years old / Restriccion de edad > 3 anos de edad. Upon request / A peticion Dolutegravir 50 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA634 (a) Ref:ANDA 208355 USFDA 2 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 20-8355 2 HIV-AIDS / VIH-SIDA Upon request / A peticion Dolutegravir+lamivudine+tenofovir 300mg/300mg/50mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 ANDA 209618 USFDA 2 ANDA 209670 USFDA 2 https://extranet.who.int/prequal/medicine/3371 ANDA 209618 USFDA 2 ANDA 209670 USFDA 2 HIV-AIDS / VIH-SIDA Efavirenz 600 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA649 Ref: HA506 * Ref: HA403 * Ref: HA399 * Ref: HA390 * Ref: HA352 * Ref: HA337 (a) Ref: HA306 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-8958 2 Ref: USFDA ANDA 07-7673 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Efavirenz + Emtricitabine + Tenofovir 600 mg + 200 mg + 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA538 * Ref: HA527 Ref: HA500 Ref: HA444 Ref: HA562 Ref: HA553 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 20-3041 2 Ref: USFDA ANDA 09-0437 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Efavirenz + Lamivudine + Tenofovir 600 mg + 300 mg + 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA466 Ref: HA611 Ref: HA593 Ref: HA549 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA NDA 22-343 2 Ref: USFDA NDA 22-142 2 Ref: USFDA NDA 20-4568 2 Ref: USFDA ANDA 90-437 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Emtricitabine 200 mg Capsule / Capsula Bottle / Frasco 30 capsules bottle / Frasco de 30 capsulas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA418 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-9188 2 Ref: USFDA ANDA 09-0488 2 HIV-AIDS / VIH-SIDA Upon request / A peticion Emtricitabine + Tenofovir 200 mg + 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA343 (a) Ref: HA417 * Ref: HA439 Ref: HA498 Ref: HA551 Ref: HA552 Ref: HA561 Ref: HA601 Ref: HA631 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 09-0513 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Etravirine 100 mg Tablet / Tableta Bottle / Frasco 120 tablets bottle / Frasco de 120 tabletas HDPE Bottle 120x1 / Frasco PEAD 120x2 Ref: HA532 (a) https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA (3) See footnote / Ver nota al pie Upon request / A peticion Etravirine 200 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HIV-AIDS / VIH-SIDA (3) See footnote / Ver nota al pie Upon request / A peticion Lamivudine 150 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 PP Bottle 60x1 / Frasco PP 60x1 Ref: HA117 (a) Ref: HA153 * Ref: HA203 * Ref: HA353 Ref: HA424 * Ref: HA644 Ref: HA282 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-7464 a 2 Ref: USFDA ANDA 09-0433 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Lamivudine + Nevirapine + Zidovudine 150 mg + 200 mg + 300 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA275 Ref: HA323 Ref: HA365 * Ref: HA426 * Ref: HA513 * Ref: HA524 * https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: Hcnda (Health Canada Access Program) Ref: USFDA NDA 21-939 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Lamivudine + Zidovudine 150 mg + 300 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA060 * Ref: HA110 (a) Ref: HA286 Ref: HA291 * Ref: HA392 * Ref: HA459 * Ref: HA485 Ref: HA490 Ref: HA521 Ref: HA655 Ref: HA659 (a) Ref: HA060 * https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-7558 2 Ref: USFDA ANDA 07-8929 2 Ref: USFDA ANDA 07-9124 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Lopinavir + Ritonavir 200 mg + 50 mg Tablet (heat stable)/ Tableta (termoestable) Bottle / Frasco 120 tablets bottle / Frasco de 120 tabletas HDPE Bottle 120x1 / Frasco PEAD 120x1 Ref: HA381 (a) Ref: HA411 * Ref: HA492 Ref: HA574 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: EMA Art 58 H-W-764-1 Ref: USFDA ANDA 09-0471 b 2 Ref: USFDA ANDA 90-371 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Nevirapine 200 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA570 Ref: HA155 * Ref: HA268 * Ref: HA298 * Ref: HA396 * Ref: HA465 * Ref: HA039 * https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-7521 2 Ref: USFDA ANDA 07-8644 2 Ref: USFDA ANDA 07-8887 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Raltegravir 400 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HIV-AIDS / VIH-SIDA (3) See footnote / Ver nota al pie Upon request / A peticion Ritonavir 100 mg Tablet (heat stable)/ Tableta (termoestable) Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA467 Ref: HA491 (a) Ref: HA563 Ref: HA565 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Tenofovir 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA329 (a) Ref: HA401 * Ref: HA410 * Ref: HA508 * Ref: HA516 Ref: HA535 * Ref: HA588 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 09-0647 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Tenofovir + Lamivudine 300 mg + 300 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA414 Ref: HA525 Ref: HA666 Ref: HA448 * Ref: HA514 * Ref: HA620 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA NDA 22-141 2 Ref: USFDA NDA 22-344 2 Ref: USFDA NDA 22-459 HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine 300 mg + 300 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA448 * https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA NDA 22-459 HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine 300 mg + 300 mg Tablet / Tableta Bottle / Frasco 100 tablets bottle / Frasco de 100 tabletas HDPE Bottle 100x1 / Frasco PEAD 100x1 Ref: HA414 Ref: HA620 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA NDA 22-141 2 Ref: USFDA NDA 22-459 HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine 300 mg + 300 mg Tablet / Tableta Blister / Blister 10 tablets blister / Blister de 10 tabletas Blister,Alu/Alu 10x1 // Blister de Alu/Alu 10x1 Ref: HA666 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine 300 mg + 300 mg Tablet / Tableta Blister / Blister 10 tablets blister / Blister de 10 tabletas Blister, Alu/cold form laminate of OPA/Alu/PVC, 10x10 // Blister de Alu y laminado de OPA/Alu/PVC, 10x10 Ref: HA514 * https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine + Efavirenz 300 mg + 300 mg + 600 mg Tablet / Tableta Bottle / Frasco 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 Ref: HA466 Ref: HA593 Ref: HA611 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 90-437 Ref: USFDA NDA 20-4568 2 Ref: USFDA NDA 22-142 2 Ref: USFDA NDA 22-343 2 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Tenofovir + Lamivudine + Efavirenz 300 mg + 300 mg + 600 mg Tablet / Tableta Container / Recipiente 30 tablets container / Recipiente de 30 tabletas HDPE Container 30x1 / Recipiente PEAD 30x1 Ref: HA549 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Tenofovir + Lamivudine + Efavirenz 300 mg + 300 mg + 600 mg Tablet / Tableta Container / Recipiente 90 tablets container / Recipiente de 90 tabletas HDPE Container 90x1 / Recipiente PEAD 90x1 Ref: HA549 https://extranet.who.int/prequal/content/prequalified-lists/medicines HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine + Efavirenz 300 mg + 300 mg + 600 mg Tablet / Tableta Container / Recipiente 100 tablets container / Recipiente de 100 tabletas HDPE Container 100x1 / Recipiente PEAD 100x1 Ref: HA549 https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 90-437 Ref: USFDA NDA 22-142 2 HIV-AIDS / VIH-SIDA Upon request / A peticion Tenofovir + Lamivudine + Efavirenz 300 mg + 300 mg + 400 mg Tablet / Tableta Container / Recipiente 30 tablets bottle / Frasco de 30 tabletas HDPE Bottle 30x1 / Frasco PEAD 30x1 ANDA 208255 USFDA 2 https://extranet.who.int/prequal/medicine/3440 ANDA 208255 USFDA 2 HIV-AIDS / VIH-SIDA Upon request / A peticion Zidovudine 300 mg Tablet / Tableta Bottle / Frasco 60 tablets bottle / Frasco de 60 tabletas HDPE Bottle 60x1 / Frasco PEAD 60x1 Ref: HA457 * Ref: HA483 Ref: HA517 Ref: HA051 * https://extranet.who.int/prequal/content/prequalified-lists/medicines Ref: USFDA ANDA 07-7267 1 Ref: USFDA ANDA 07-8922 1 HIV-AIDS / VIH-SIDA http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=35058&lang=es Zidovudine 10 mg/ml Solution for injection / Solucion para inyeccion Vial / Vial 20 ml vial / vial de 20 ml Vial Glass: 20x5 / Frasco vial 20x5 Ref: HA114 (a) https://extranet.who.int/prequal/content/prequalified-lists/medicines Upon request / A peticion (1) Link to list of approved products is https://extranet.who.int/prequal/content/prequalified-lists/medicines. El Enlace a la lista de productos aprobados es https://extranet.who.int/prequal/content/prequalified-lists/medicines (2) The price stated in the link (if available) is to be used as reference, since such price could be variable among different suppliers. El precio indicado en el enlace (si esta disponible) se utiliza como referencia, ya que dicho precio podria ser varia (3) Procurement of this medicine through the Strategic Fund should be limited for use as third-line therapy in treatment-experienced HIV adults who failed second-line antiretroviral therapy. It is recommended patients receiving HIV/AIDS regimens including (3) La adquisicion de este medicamento a traves del Fondo Estrategico debe ser limitada para su uso como tratamiento de tercera linea en adultos con VIH tratados previamente que reprobaron la terapia antirretroviral de segunda linea. Se recomienda que los